<DOC>
	<DOCNO>NCT01481740</DOCNO>
	<brief_summary>Previous research regard use phenylephrine exclude obese subject ( BMI &gt; 35 ) . This subgroup patient represent large portion obstetric patient population locally nationally . It unclear whether previous research extrapolate obese patient population . This study do compare incidence hypotension , intraoperative nausea vomiting , neonatal acidosis obese patient receive prophylactic phenylephrine infusion versus receive phenylephrine boluses treatment establish hypotension . This study help u determine whether use phenylephrine infusion phenylephrine bolus best way prevent/treat spinal induced hypotension cesarean delivery obese patient .</brief_summary>
	<brief_title>Preventing Hypotension Parturients With Elevated Body Mass Index ( BMI )</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<criteria>English speaking ASA Physical Status III Nonlaboring woman Single gestation â‰¥ 36 week Obese woman ( Body Mass Index 35 55 kg/m2 ) Nonemergent CD spinal anesthesia Height &lt; 5 ' 0 '' Antiemetic drug use 24 hour prior CD Allergy phenylephrine , standardized medication Hypertensive disease pregnancy ( i.e . mild &amp; severe preeclampsia ) Chronic hypertension receive antihypertensive treatment Severe Cardiac disease pregnancy mark functional limitation Patients Monoamine Oxidase Inhibitors Tricyclic Antidepressants Subject enrollment another study involve study medication within 30 day CD Any physical psychiatric condition may impair ability cooperate study data collection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>spinal induce hypotension</keyword>
	<keyword>nausea vomit</keyword>
	<keyword>cesarean delivery</keyword>
</DOC>